1. Whiteside TL . Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol 2006; 16: 3–15.
2. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL . Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 2002; 8: 3137–3145.
3. Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT et al. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 2002; 8: 2553–2562.
4. Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL . Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999; 5: 1263–1273.
5. Gastman BR, Atarashi Y, Reichert TE, Saito T, Balkir L, Rabinowich H et al. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes. Cancer Res 1999; 59: 5356–5364.